<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03717116</url>
  </required_header>
  <id_info>
    <org_study_id>83045809-604.01.02, A-01</org_study_id>
    <nct_id>NCT03717116</nct_id>
  </id_info>
  <brief_title>Early Prediction of Hypocalcemia After Thyroidectomy Using Postoperative Second Hour Parathormone</brief_title>
  <official_title>Early Prediction of Hypocalcemia After Thyroidectomy Using Postoperative Second Hour Parathormone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypocalcemia is the most frequent complication in thyroid surgeries. Diagnosing this
      complication earlier will reduce longer hospital stay and will lead to an earlier
      intervention. The purpose of the study is to evaluate postoperative second hour parathyroid
      hormone measurement as a predictor for early stage hypocalcemia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>postoperative parathormone level</measure>
    <time_frame>postoperative 2. hour</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Hypocalcemia, Postoperative Parathormone</condition>
  <arm_group>
    <arm_group_label>control-normocalcemia group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>hypocalcemia group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>parathormone level</intervention_name>
    <description>From the patients, blood will be taken preoperatively and postoperatively.</description>
    <arm_group_label>control-normocalcemia group</arm_group_label>
    <arm_group_label>hypocalcemia group</arm_group_label>
    <other_name>calcium level</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples for biochemical evaluation
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        all patients with multinodular goiter, Graves, fine needle aspiartion biopsy with Bethesda
        3-4 undergoing total thyroidectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with multinodular goiter, Graves, fine needle aspiartion biopsy with Bethesda
             3-4 undergoing total thyroidectomy

        Exclusion Criteria:

          -  pregnant women

          -  patients with thyroid cancer or previous neck dissection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>selen soylu</last_name>
    <phone>+905375653811</phone>
    <email>selen_soylu@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istanbul University</name>
      <address>
        <city>Istanbul</city>
        <zip>34158</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>selen soylu, MD</last_name>
      <phone>5375653811</phone>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>October 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2018</study_first_posted>
  <last_update_submitted>October 22, 2018</last_update_submitted>
  <last_update_submitted_qc>October 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Selen Soylu, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>hypocalcemia, parathormone, bone density</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypocalcemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parathyroid Hormone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

